Aladdin HC: Warum gibts zu dieser Corona-Aktie noch keinen Thread? (Seite 4)
eröffnet am 16.03.20 19:15:41 von
neuester Beitrag 12.10.22 17:10:13 von
neuester Beitrag 12.10.22 17:10:13 von
Beiträge: 269
ID: 1.321.930
ID: 1.321.930
Aufrufe heute: 0
Gesamt: 27.602
Gesamt: 27.602
Aktive User: 0
ISIN: DE000A12ULL2 · WKN: A12ULL · Symbol: NMI
0,0020
EUR
0,00 %
0,0000 EUR
Letzter Kurs 02.05.24 Düsseldorf
Werte aus der Branche Informationstechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,0000 | +99.999,00 | |
| 15,850 | +210,78 | |
| 0,5810 | +32,62 | |
| 13,600 | +24,54 | |
| 3,0000 | +20,00 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 22,200 | -17,78 | |
| 4,5500 | -18,17 | |
| 14,700 | -19,45 | |
| 37,01 | -25,85 | |
| 8,7900 | -32,02 |
Beitrag zu dieser Diskussion schreiben
Feedback
Was ist denn heute los? Gibt's vielleicht den Bericht? Oder ein Listing?
Wer hier sein Geld versenkt ist selbst Schuld!
Gestern immer wieder Größe Blöcke gesucht, aber kein Verkaufsdruck mehr. Wie kann es weiter gehen ... ein paar RobinHood Aktivisten wären schön ...
Nicht schlecht der CEO scheint ja nix zutun zu haben, wenn er zeit hat dir zu antworten....
Spricht für meine Theorie das hinter diesem Unternehmen nix als heiße Luft steckt !
Die ist mit dem aktuellen Kurs noch viel zu hoch bewertet, bei dem Schuldenberg.....
Null Eigenkapital vorhanden.
Ich würde an eurer Stelle noch schnell das sinkende Schiff verlassen, bevor ihr eine Depotleiche besitzt...
Spricht für meine Theorie das hinter diesem Unternehmen nix als heiße Luft steckt !
Die ist mit dem aktuellen Kurs noch viel zu hoch bewertet, bei dem Schuldenberg.....
Null Eigenkapital vorhanden.
Ich würde an eurer Stelle noch schnell das sinkende Schiff verlassen, bevor ihr eine Depotleiche besitzt...
Antwort auf Beitrag Nr.: 66.610.994 von savvas1987 am 26.01.21 11:37:21Die Aktie sollte Mal von wallstreetbets gepusht werden. Das wär ne Chance auf Höhe Kurse lol
Trading Spotlight
Ja..es hat mich auch gewundert wie schnell er geantwortet hat. Ich hab ihm aber erst per linked chat in geschrieben. Es hat sich vieles in der Firma verändert. High hopes!
Antwort auf Beitrag Nr.: 66.609.002 von savvas1987 am 26.01.21 10:01:50Also ich hatte Ihn letzte Jahr angeschrieben und bis dato keine Antwort erhalten, alles sehr komisch 🤷♂️
Mail from Wade
Wade Smith hat auf einer Mail von mir geantwortet. Just for everybodys info.
Antwort auf Beitrag Nr.: 66.608.705 von savvas1987 am 26.01.21 09:49:26
Woher ist das? Quelle? Hast du dir das selber ausgedacht?
Zitat von savvas1987: Further to your request for an update on Aladdin Healthcare Technologies share position of its shares, I would like to confirm some basic key facts which are both my own and some of which are in the public domain.
The decline of Aladdin’s stock is for the following reasons:
Two shareholders in some size, but not management sold a lot of shares aggressively into good news that we Produced over the last 18 months and as a consequence this pushed down the shares and gave a vote of no confidence to the market. This also alerted media which also made the situation worse.
There has not been any coverage of the company’s stock in Germany and Europe from an analyst.
The business is under capitalised and did not raise capital as it was instigated during the market collapse in early 2020.
The audit 2019 was late.
Lack of understanding and general undervaluing European science-based AI companies that are listed in Europe.
Remedies and answers to the above:
The selling has stopped for by the shareholders now and we are now in the process of rebuilding the share price. This will be accelerated by the listing of the company’s shares on one of the OTC markets in the US in the next month. This is significant as the US is the main risk capital market that understands the value of leading AI and science. Volume potential is 20 to 50X.
We have already announced we are making a move to the OTCQX publicly, but we cannot promise it will be QX as there are higher capital hurdles to overcome. However, we have filed a 211 form with FINRA in the US and expect to gain approval a date for listing in the next two weeks. Regulators take some time some patience is required. We have appointed a very good market maker and have a very strong programme moving forward, so I expect there to be a very strong appetite for the shares.
We have appointed a Berlin based broker to put out research in Q1 2021. However, we may upgrade this to another specialist for our space.
We are seeking to raise capital in the US in Q1 on anticipation of an elevated share price. We have the placement agent in place to do this.
We have redone 2018 and 2019 audits through Grant Thornton which has put our accounts in a good state. Once we raise capital, we can then have a report with an un-qualified opinion which puts us in a great position vs historically. Therefore, I anticipate 2020 will be filed on time.
We are remedying this by listing in the US where we have a stronger network of brokers and advisers.
Scope for the share price:
Clearly at these levels, we are not satisfied and really need to move the share price above EUR 5 over the next 6 months. This is not a statement, but where I personally believe the company should be at a minimum. We are also moving into some exciting new healthcare sectors which we believe will form a good focus for the company and drive further intrinsic value.
Woher ist das? Quelle? Hast du dir das selber ausgedacht?
Info von Wade Smith
Further to your request for an update on Aladdin Healthcare Technologies share position of its shares, I would like to confirm some basic key facts which are both my own and some of which are in the public domain. The decline of Aladdin’s stock is for the following reasons:
Two shareholders in some size, but not management sold a lot of shares aggressively into good news that we Produced over the last 18 months and as a consequence this pushed down the shares and gave a vote of no confidence to the market. This also alerted media which also made the situation worse.
There has not been any coverage of the company’s stock in Germany and Europe from an analyst.
The business is under capitalised and did not raise capital as it was instigated during the market collapse in early 2020.
The audit 2019 was late.
Lack of understanding and general undervaluing European science-based AI companies that are listed in Europe.
Remedies and answers to the above:
The selling has stopped for by the shareholders now and we are now in the process of rebuilding the share price. This will be accelerated by the listing of the company’s shares on one of the OTC markets in the US in the next month. This is significant as the US is the main risk capital market that understands the value of leading AI and science. Volume potential is 20 to 50X.
We have already announced we are making a move to the OTCQX publicly, but we cannot promise it will be QX as there are higher capital hurdles to overcome. However, we have filed a 211 form with FINRA in the US and expect to gain approval a date for listing in the next two weeks. Regulators take some time some patience is required. We have appointed a very good market maker and have a very strong programme moving forward, so I expect there to be a very strong appetite for the shares.
We have appointed a Berlin based broker to put out research in Q1 2021. However, we may upgrade this to another specialist for our space.
We are seeking to raise capital in the US in Q1 on anticipation of an elevated share price. We have the placement agent in place to do this.
We have redone 2018 and 2019 audits through Grant Thornton which has put our accounts in a good state. Once we raise capital, we can then have a report with an un-qualified opinion which puts us in a great position vs historically. Therefore, I anticipate 2020 will be filed on time.
We are remedying this by listing in the US where we have a stronger network of brokers and advisers.
Scope for the share price:
Clearly at these levels, we are not satisfied and really need to move the share price above EUR 5 over the next 6 months. This is not a statement, but where I personally believe the company should be at a minimum. We are also moving into some exciting new healthcare sectors which we believe will form a good focus for the company and drive further intrinsic value.
Durchsuchen
